BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Clofibrate
,
rs2230926
,
DRD2
,
Apoptosis
,
HIV infection
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tcr cd3 complex
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
T-cell leukemia ALL-SIL cells with DLL1 stimulated TCR activation or with TLX1 shRNA
T-lymphocytes activated with anti-CD3 anti-CD28 and overexpressing BCL6
Regulatory and conventional T cells from TRIM28-knockout mice stimulated with anti-CD3 and anti-CD28
CD8+ T cells resistant or sensitive to cyclosporine
Explore Curated Studies Results
Literature
Most Relevant Literature
Enhancing the Antitumor Immunity of T Cells by Engineering the Lipid-Regulatory Site of the TCR/CD3 …
The Full Model of the pMHC-TCR-CD3 Complex: A Structural and Dynamical Characterization of Bound and…
Cholesterol inhibits TCR signaling by directly restricting TCR-CD3 core tunnel motility.
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in…
Experimentally Guided Computational Methods Yield Highly Accurate Insights into Transmembrane Intera…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regi…
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR G…
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 …
Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning…
Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ